GOLDEN, Colo., April 02, 2025--Published analysis showed the GEMCOVAC-OM COVID-19 booster administered exclusively with Tropis ID induced a broad and long-lasting immune response.

A study published this week in NPJ Vaccines found that a new type of mRNA vaccine could more easily adapt to protect against constantly evolving viruses such as COVID-19 and the bird flu.

Publication in npj Vaccines Reports Cross-reactive and Long-Lasting Immune Responses for self-amplifying mRNA (samRNA) COVID-19 Vaccine Booster Administered Intradermally with PharmaJet Tropis® ...

npj Vaccines is part of the npj Series: open access community journals from Nature Portfolio publishing high-quality research, reviews and commentary across the life, health, physical, applied and ...

In a study published in npj Vaccines, mice immunized intranasally with the new T-vant vaccine showed no signs of the bacteria in the lungs and nasopharynx – the upper throat area behind the nose ...

npj Vaccines is a multidisciplinary journal that is dedicated to publishing the finest and high-quality research and development on human and veterinary vaccines. Publisher Nature Publishing Group ...

npj Vaccines is a new open access, online-only, journal, which is part of the Nature Research portfolio and published in partnership with the University of Texas Medical Branch, Sealy Center for ...